AI assistant
GLOBUS MEDICAL INC — Director's Dealing 2012
Aug 10, 2012
30771_dirs_2012-08-10_29871aed-6b9a-4200-af4c-78d5cf97cd2c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GLOBUS MEDICAL INC (GMED)
CIK: 0001237831
Period of Report: 2012-08-08
Reporting Person: WHEELER KURT (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-08-08 | Class A Common Stock | C | 7444168 | $0.00 | Acquired | 8048433 | Indirect |
| 2012-08-08 | Class A Common Stock | S | 804232 | $11.16 | Disposed | 7244201 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-08-08 | Series E Preferred Stock | $ | C | 7444168 | Disposed | Class A Common Stock (7444168) | Indirect |
Footnotes
F1: The Company's Series E Preferred Stock automatically converted into the Company's Class A Common Stock on a one-for-one basis upon the closing of the Company's initial public offering and had no expiration date.
F2: Clarus Ventures I Management, L.P. ("Clarus I Management") is the sole general partner of Clarus Lifesciences I, L.P. and Clarus Ventures I, LLC ("Clarus I GPLLC") is the sole general partner of Clarus I Management. Mr. Wheeler is a managing director of Clarus I GPLLC. As a managing director of Clarus I GPLLC, Mr. Wheeler has shared voting and disposition power related to these shares and disclaims beneficial ownership of these shares.